Impact of oral hypoglycemic agents on mortality among diabetic patients with non-muscle-invasive bladder cancer: A populationbased analysis

INTRODUCTION: Non-muscle-invasive bladder cancer (NMIBC) accounts for 75–85% of all urothelial bladder cancers (UBC). Many UBC patients are also afflicted by diabetes mellitus (DM). It has been postulated that several oral hypoglycemic agents could impact disease-specific survival (DSS), but the dat...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Can Urol Assoc J
Autors principals: Richard, Patrick O., Ahmad, Ardalan E., Bashir, Shaheena, Zlotta, Alexandre, Bhindi, Bimal, Leao, Ricardo, Nayan, Madhur, Mohammed, Aza, Fleshner, Neil E., Kulkarni, Girish S.
Format: Artigo
Idioma:Inglês
Publicat: Canadian Medical Association 2018
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC5994977/
https://ncbi.nlm.nih.gov/pubmed/29485035
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5489/cuaj.4870
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars